Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer's disease?

Franck Hansmannel, Corinne Lendon, Florence Pasquier, Julie Dumont, Didier Hannequin, Julien Chapuis, Geoffroy Laumet, Anne Marie Ayral, Daniela Galimberti, Elio Scarpini, Dominique Campion, Philippe Amouyel, Jean Charles Lambert

Research output: Contribution to journalArticlepeer-review


Expression of ornithine transcarbamylase (OTC) is strongly induced in the brain of individuals suffering from Alzheimer's Disease (AD). Association studies in a population from northern France have revealed that two SNPs -389 G/A (rs5963409) and -241 A/G (rs5963411) located in the promoter of the OTC gene are associated with the risk of developing AD. In the present work, these association studies were extended to a population of 2113 AD cases and 1580 controls from northern France, western France, the United Kingdom and Italy. The rs5963409 minor allele was weakly but significantly associated with an increased risk of developing AD (OR = 1.19, p = 0.004). This association was independent of age and ApoE status. Our results support that the OTC gene may be a minor genetic determinant of AD.

Original languageEnglish
Pages (from-to)76-80
Number of pages5
JournalNeuroscience Letters
Issue number1
Publication statusPublished - Jan 2 2009


  • Alzheimer
  • Association study
  • Ornithine transcarbamylase
  • Polymorphism
  • Urea cycle

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer's disease?'. Together they form a unique fingerprint.

Cite this